Sodium‐glucose cotransporter‐2 inhibitors in heart failure: an updated meta‐analysis

AIMS: We aimed to examine efficacy and safety outcomes of sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) for the treatment of heart failure (HF), especially in patients with heart failure with preserved ejection fraction (HFpEF). METHODS AND RESULTS: PubMed, Web of Science, and Cochrane Library w...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yang, Li, Pengxiao, Li, Yi, Han, Yaling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065870/
https://www.ncbi.nlm.nih.gov/pubmed/35338608
http://dx.doi.org/10.1002/ehf2.13905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065870/
https://www.ncbi.nlm.nih.gov/pubmed/35338608
http://dx.doi.org/10.1002/ehf2.13905

Ejemplares similares